
Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2025, titled "Emcutix and WiQo Sign Exclusive Licensing Partnership to revolutionize Derma-cosmetic Treatments in India".
Filed with NSE ·

Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2025, titled "Emcutix and WiQo Sign Exclusive Licensing Partnership to revolutionize Derma-cosmetic Treatments in India".
6ix hasn’t read this filing yet.
Emcure Pharmaceuticals Limited on 6ix
Follow Emcure Pharmaceuticals into a list and get an email when it puts out news.
Follow Emcure Pharmaceuticals